Published in PLoS One on January 23, 2013
From neural development to cognition: unexpected roles for chromatin. Nat Rev Genet (2013) 2.42
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev (2013) 2.07
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers. Proc Natl Acad Sci U S A (2014) 1.71
Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun (2013) 1.62
Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev (2015) 1.58
Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet (2013) 1.53
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PLoS One (2016) 1.44
From human genome to cancer genome: the first decade. Genome Res (2013) 1.42
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics. Sci Adv (2015) 1.33
Regulating the chromatin landscape: structural and mechanistic perspectives. Annu Rev Biochem (2014) 1.29
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. Mol Cell Biol (2014) 1.28
Requirement for PBAF in transcriptional repression and repair at DNA breaks in actively transcribed regions of chromatin. Mol Cell (2014) 1.23
The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther (2014) 1.21
Vulnerabilities of mutant SWI/SNF complexes in cancer. Cancer Cell (2014) 1.20
A rationale to target the SWI/SNF complex for cancer therapy. Trends Genet (2014) 1.17
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet (2015) 1.15
ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci (2013) 1.14
A regulatory network of Drosophila germline stem cell self-renewal. Dev Cell (2014) 1.13
Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights. Clin Cancer Res (2013) 1.07
Long noncoding RNAs in cancer: from function to translation. Trends Cancer (2015) 1.06
Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. Oncotarget (2014) 1.03
The mutational landscape of chromatin regulatory factors across 4,623 tumor samples. Genome Biol (2013) 1.03
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells. Elife (2015) 1.03
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies. Cancer Res (2015) 0.99
Driver mutations of cancer epigenomes. Protein Cell (2014) 0.98
Targeting EZH2 and PRC2 dependence as novel anticancer therapy. Exp Hematol (2015) 0.95
Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression. Cell Cycle (2016) 0.93
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. J Pathol (2015) 0.92
Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. PLoS Genet (2015) 0.92
INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma. Genes Dev (2016) 0.91
Chromatin-regulating proteins as targets for cancer therapy. J Radiat Res (2014) 0.88
The mini-driver model of polygenic cancer evolution. Nat Rev Cancer (2015) 0.87
PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma. PLoS One (2016) 0.87
Chromatin Remodelers: From Function to Dysfunction. Genes (Basel) (2015) 0.86
BAF180 promotes cohesion and prevents genome instability and aneuploidy. Cell Rep (2014) 0.86
Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. Am J Pathol (2014) 0.86
From melanocytes to melanomas. Nat Rev Cancer (2016) 0.85
Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states. Nat Genet (2016) 0.85
Expression inactivation of SMARCA4 by microRNAs in lung tumors. Hum Mol Genet (2014) 0.84
Genetic alterations in hepatocellular carcinoma: An update. World J Gastroenterol (2016) 0.83
PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest. Oncotarget (2015) 0.83
Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance. Pediatr Blood Cancer (2014) 0.83
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type. Orphanet J Rare Dis (2015) 0.83
Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability. Nat Commun (2016) 0.81
Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype. Epigenetics Chromatin (2015) 0.81
The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. J Cell Physiol (2015) 0.81
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches. Mol Cell (2015) 0.81
The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer. Cold Spring Harb Perspect Med (2016) 0.81
SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma. Crit Rev Eukaryot Gene Expr (2014) 0.80
SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance. PLoS One (2015) 0.80
SWI/SNF complexes are required for full activation of the DNA-damage response. Oncotarget (2015) 0.80
ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy. Adv Cancer Res (2014) 0.80
Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia. Leukemia (2016) 0.80
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). Rare Dis (2014) 0.79
It takes two to tango, a dance between the cells of origin and cancer stem cells in the Drosophila larval brain. Semin Cell Dev Biol (2014) 0.79
The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure. Surg Clin North Am (2015) 0.79
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer. Cancer Res (2017) 0.79
Detecting protein complexes in protein interaction networks using a ranking algorithm with a refined merging procedure. BMC Bioinformatics (2014) 0.78
Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours. Histopathology (2016) 0.78
Whole genome expression profiling shows that BRG1 transcriptionally regulates UV inducible genes and other novel targets in human cells. PLoS One (2014) 0.78
Nucleosome remodelling, DNA repair and transcriptional regulation build negative feedback loops in cancer and cellular ageing. Philos Trans R Soc Lond B Biol Sci (2017) 0.78
TOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin. Nat Struct Mol Biol (2017) 0.77
Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells. Oncotarget (2016) 0.77
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. Clin Cancer Res (2016) 0.77
Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex. J Med Chem (2016) 0.77
Functional Interplay of Two Paralogs Encoding SWI/SNF Chromatin-Remodeling Accessory Subunits During Caenorhabditis elegans Development. Genetics (2016) 0.77
SMARCA4 regulates gene expression and higher-order chromatin structure in proliferating mammary epithelial cells. Genome Res (2016) 0.77
The INO80 Complex Requires the Arp5-Ies6 Subcomplex for Chromatin Remodeling and Metabolic Regulation. Mol Cell Biol (2016) 0.77
Marked for death: targeting epigenetic changes in cancer. Nat Rev Drug Discov (2017) 0.76
Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma. PLoS One (2015) 0.76
Chromatin-Remodeling Complex SWI/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1. Cancer Res (2016) 0.76
BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways. Oncogene (2016) 0.76
SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer. Genes Dev (2016) 0.75
The Swi3 protein plays a unique role in regulating respiration in eukaryotes. Biosci Rep (2016) 0.75
The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression. Mol Cell Proteomics (2015) 0.75
Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition. BMC Cancer (2016) 0.75
Chromatin Remodeler Recruitment during Macrophage Differentiation Facilitates Transcription Factor Binding to Enhancers in Mature Cells. J Biol Chem (2016) 0.75
Driver gene classification reveals a substantial overrepresentation of tumor suppressors among very large chromatin-regulating proteins. Sci Rep (2016) 0.75
From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers. Int J Mol Sci (2017) 0.75
Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia. Front Immunol (2015) 0.75
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia (2016) 0.75
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes. BMC Med Genomics (2015) 0.75
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation. Oncotarget (2016) 0.75
Altered oncomodules underlie chromatin regulatory factors driver mutations. Oncotarget (2016) 0.75
The roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemia. Biomed Res Int (2015) 0.75
Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors. Am J Cancer Res (2017) 0.75
Antagonistic roles of Drosophila Tctp and Brahma in chromatin remodelling and stabilizing repeated sequences. Nat Commun (2016) 0.75
SWI/SNF Infobase-An exclusive information portal for SWI/SNF remodeling complex subunits. PLoS One (2017) 0.75
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior. Mod Pathol (2017) 0.75
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma. Histopathology (2017) 0.75
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor. Cancer Sci (2017) 0.75
ARID1B alterations identify aggressive tumors in neuroblastoma. Oncotarget (2017) 0.75
A method and server for predicting damaging missense mutations. Nat Methods (2010) 78.53
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30
ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med (2010) 13.07
Frequent pathway mutations of splicing machinery in myelodysplasia. Nature (2011) 11.44
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med (2011) 11.07
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science (2010) 10.78
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature (1998) 7.55
Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet (2011) 7.31
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A (2012) 7.14
SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer (2011) 6.87
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet (2011) 6.43
Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae. Genetics (1984) 6.09
Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet (2011) 6.06
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet (2011) 5.68
The SWI/SNF complex and cancer. Oncogene (2009) 5.05
TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol (2010) 4.92
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38
Five SWI genes are required for expression of the HO gene in yeast. J Mol Biol (1984) 4.20
An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A (2009) 4.07
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat (2011) 3.63
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A (2011) 3.51
Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science (2011) 3.49
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet (2011) 3.10
Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum Mutat (2008) 3.02
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci U S A (2000) 2.91
Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell (2010) 2.80
Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet (2012) 2.75
ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res (2011) 2.71
Precursors to invasive pancreatic cancer. Adv Anat Pathol (2005) 2.45
Diverse roles and interactions of the SWI/SNF chromatin remodeling complex revealed using global approaches. PLoS Genet (2011) 2.38
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat Genet (2011) 2.36
An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. Oncogene (2011) 2.23
BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer. Cancer Res (2008) 2.06
Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res (2009) 2.03
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc Natl Acad Sci U S A (2012) 1.90
Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Genome Res (2011) 1.47
Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Genes Chromosomes Cancer (2004) 1.27
Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics (2011) 1.01
Mutations and deletions of ARID1A in breast tumors. Oncogene (2012) 1.00
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Hum Pathol (2011) 0.99
Endometriosis-associated ovarian carcinomas. N Engl J Med (2011) 0.91
Evolutionary and biomedical insights from the rhesus macaque genome. Science (2007) 16.21
Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med (2004) 9.81
Molecular characterisation of soft tissue tumours: a gene expression study. Lancet (2002) 7.05
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer (2006) 5.39
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One (2009) 4.62
Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol (2006) 4.49
Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res (2005) 3.98
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res (2007) 3.13
A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol (2002) 3.09
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood (2008) 3.03
A DNA microarray survey of gene expression in normal human tissues. Genome Biol (2005) 2.90
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol (2003) 2.59
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. Mod Pathol (2007) 2.47
Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia (2005) 2.35
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med (2006) 2.16
Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches. Blood (2006) 2.14
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol (2012) 2.12
Gene copy number variation spanning 60 million years of human and primate evolution. Genome Res (2007) 2.02
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc Natl Acad Sci U S A (2012) 1.90
RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes. Genes Chromosomes Cancer (2006) 1.72
LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer Res (2010) 1.55
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res (2005) 1.52
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. Blood (2008) 1.51
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol (2003) 1.49
Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. J Mol Diagn (2007) 1.44
Genomic instability in breast cancer: pathogenesis and clinical implications. Mol Oncol (2010) 1.43
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. PLoS Genet (2008) 1.39
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res (2005) 1.30
Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. J Mol Diagn (2005) 1.29
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia. Blood (2007) 1.28
Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res (2010) 1.27
A gene expression signature of genetic instability in colon cancer. Cancer Res (2005) 1.23
Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. Prostate (2005) 1.20
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types. PLoS Genet (2013) 1.19
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Mol Oncol (2008) 1.16
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Res (2010) 1.13
DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics (2009) 1.05
A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer. PLoS One (2011) 1.03
Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS One (2011) 1.03
The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Res (2003) 0.99
CDX2 is an amplified lineage-survival oncogene in colorectal cancer. Proc Natl Acad Sci U S A (2012) 0.99
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. Am J Surg Pathol (2008) 0.98
High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas. Diagn Mol Pathol (2004) 0.96
KIT mutations confer a distinct gene expression signature in core binding factor leukaemia. Br J Haematol (2010) 0.94
A fused lasso latent feature model for analyzing multi-sample aCGH data. Biostatistics (2011) 0.94
SMURF1 amplification promotes invasiveness in pancreatic cancer. PLoS One (2011) 0.94
Gene expression profiling in prostate cancer cells with Akt activation reveals Fra-1 as an Akt-inducible gene. Mol Cancer Res (2003) 0.94
Comparative genomic hybridization on mouse cDNA microarrays and its application to a murine lymphoma model. Oncogene (2005) 0.93
Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. Prostate (2008) 0.91
Integrative genomic and functional profiling of the pancreatic cancer genome. BMC Genomics (2013) 0.89
Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. PLoS One (2013) 0.86
Physical mapping of genes in somatic cell radiation hybrids by comparative genomic hybridization to cDNA microarrays. Genome Biol (2002) 0.84
Comparative genomic hybridization on spotted oligonucleotide microarrays. Methods Mol Biol (2009) 0.81
Integration of diverse microarray data types. Methods Mol Biol (2009) 0.79
Target discovery and validation in pancreatic cancer. Methods Mol Biol (2007) 0.77
Chromosome instability leaves its mark. Nat Genet (2006) 0.75
Genomics in myeloid leukemias: an array of possibilities. Rev Clin Exp Hematol (2005) 0.75
Application of genomic technologies to human prostate cancer. OMICS (2006) 0.75